DE LISI, Stefania
DE LISI, Stefania
HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION
2009-01-01 DI MARCO, V.; Calvaruso, V.; DE LISI, S.; Ferraro, D.; Pizzillo, P.; Alaimo, G.; Peralta, S.; Craxi, A.
PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response
2009-01-01 Calvaruso, V; Di Marco, V; Almasio, PL; De Lisi, S; Ferraro, D; Pizzillo, P; Peralta, S; Craxì, A
PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE
2009-01-01 Calvaruso, V.; DI MARCO, V.; Almasio, P.; DE LISI, S.; Ferraro, D.; Pizzillo, P.; Peralta, S.; Craxi, A.
PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response
2009-01-01 Calvaruso, V; Di Marco, V; Almasio, PL; De Lisi, S; Ferraro, D; Pizzillo, P; Peralta, S; Craxì, A
The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study.
2006-01-01 DI MARCO, V.; Almasio, P.; DE LISI, S.; Calvaruso, V.; Ferraro, D.; Peralta, S.; Parisi, P.; Alaimo, G.; Alessi, N.; DI STEFANO, R.; Crax, A.
The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study
2007-01-01 VDI MARCO; VCALVARUSO; SDE LISI; PLALMASIO; FERRARO D; SPERALTA; PPARISI; GALAIMO; NALESSI; R DISTEFANO; ACRAX
Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis.
2006-01-01 DI MARCO V; DE LISI S; LI VECCHI M; MARINGHINI S; BARBARIA F